Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Nov 23;12:779453. doi: 10.3389/fimmu.2021.779453

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Ostrowski, Søgaard, Tolstrup, Stærke, Lundgren, Østergaard and Hvas

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Study design. Eighty participants (n=80) included in the Danish national vaccine trial ENFORCE, recently vaccinated with AZ or mRNA vaccines against COVID-19 were invited to provide an early blood sample post-vaccination (median of 11 days (range 8-16) post-vaccination). Pre-vaccination samples were available from all participants via the ENFORCE study. Since standard coagulation tests, platelet aggregation, whole blood coagulation (Thromboelastometry) and thrombin generation were not available at the pre-vaccination sample, non-vaccinated age and gender matched healthy individuals were invited to participate as controls.